16 / 16
16
1600 7th Avenue South
Birmingham, Alabama 35233
Clinical Trials
Open to Hem/Onc/BMT Patients
Dr. Gregory Friedman’s innovative Phase 1
Clinical Trial of HSV G207 uses a modified
virus to attack difficult-to-treat brain tumors.
Dr. Friedman’s trial is the culmination
of many years of hard work that began
when he was a fellow at Children’s of
Alabama. The trial is the true definition of
developmental therapeutics, with the hope
for more effective and less toxic treatments
for our children battling brain cancers.
We are currently recruiting patients from
across the country.
Contact (205) 638-5840 for more information.